annual meeting program - American Society of Clinical Oncology

SATURDAY
Saturday, June 5, 2010
3:00 PM - 6:00 PM
ORAL ABSTRACT SESSION
Patient and Survivor Care
Location: E354b
CME credit: 3
Track(s): Patient and Survivor Care
Teresa Gilewski, MD—Co-Chair
Memorial Sloan-Kettering Cancer Center
Barbara A. Murphy, MD—Co-Chair
Vanderbilt University Medical Center
3:00 PM Hepatitis B screening and positivity prior to chemotherapy. (Abstract #9008)
J. Hwang, M. Fisch, H. Zhang, M. A. Kallen, M. Routbort, L. Lal, J. Vierling,
M. Suarez-Almazor
3:15 PM Prevalence of hepatitis B surface antigen and hepatitis B core antibody in a
population initiating immunosuppressive therapy. (Abstract #9009)
E. Ludwig, R. B. Mendelsohn, Y. Taur, M. Kamboj, S. Nagula, K. Sepkowitz,
A. D. Zelenetz
Discussion
3:30 PM Sandra L. Wong, MD, MS (Abstracts #9008–9009)
University of Michigan Health Systems
3:45 PM Yield from risk-based screening in adults treated for cancer in childhood.
(Abstract #9010)
M. M. Hudson, V. G. Nolan, K. K. Ness, G. T. Armstrong, D. M. Green, K. R. Krull,
S. L. Spunt, M. Metzger, D. K. Srivastava, L. L. Robison
4:00 PM Executive functions in aging adult survivors of childhood leukemia.
(Abstract #9011)
K. R. Krull, N. Jain, Z. Pan, K. Shine, D. K. Srivastava, D. Stewart, C. Jones,
L. L. Robison, M. M. Hudson
4:15 PM Contrasting effects of religious/spiritual support from religious communities
versus medical teams on advanced cancer patient end-of-life care. (Abstract
#9012)
T. A. Balboni, M. E. Paulk, M. J. Balboni, A. C. Phelps, T. Vanderweele,
A. A. Wright, S. Block, H. G. Prigerson
Discussion
4:30 PM Betty R. Ferrell, RN, PhD, FAAN (Abstracts #9010–9012)
City of Hope
4:45 PM Effect of YOCAS yoga on sleep, fatigue, and quality of life: A URCC CCOP
randomized, controlled clinical trial among 410 cancer survivors. (Abstract
#9013)
K. M. Mustian, O. Palesh, L. Sprod, L. J. Peppone, C. E. Heckler, J. S. Yates,
P. S. Reddy, M. Melnik, J. K. Giguere, G. R. Morrow
5:00 PM Prevention of pegfilgrastim-induced bone pain (PIP): A URCC CCOP
randomized, double-blind, placebo-controlled trial of 510 cancer patients.
(Abstract #9014)
J. J. Kirshner, C. E. Heckler, S. R. Dakhil, J. O. Hopkins, C. Coles, G. R. Morrow
5:15 PM A meta-analysis of results from two randomized, double-blind studies of
denosumab versus zoledronic acid (ZA) for treatment of bone metastases.
(Abstract #9015)
A. Lipton, A. Stopeck, R. von Moos, D. H. Henry, G. E. Richardson,
G. I. Rodriguez, H. P. Bourgeois, C. Ke, S. June, R. D. Dansey
182